Widely used:Recently Viewed
Clear All
Value Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹1,06,555 Cr
P/E Ratio
52.2
P/B Ratio
7.64
Industry P/E
37.5
Debt to Equity
0.02
ROE
23.15 %
ROCE
28.38 %
Div. Yield
0 %
Book Value
338.08
EPS
50.68
CFO
₹8,475.84 Cr
EBITDA
₹13,636.91 Cr
Net Profit
₹9,936.03 Cr
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Mankind Pharma
| -10.37 | 17.28 | 1.43 | 13.18 | -- | -- | -- |
|
BSE Sensex
| 0.39 | 6.40 | 1.96 | 7.69 | 10.43 | 20.75 | 10.61 |
|
BSE Healthcare
| -7.68 | 6.11 | -2.04 | 19.11 | 18.77 | 22.70 | 8.84 |
|
2024
|
|
|---|---|
|
Mankind Pharma
| 45.53 |
|
BSE Sensex
| 8.10 |
|
BSE Healthcare
| 43.09 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | P/E Ratio | ROE |
|---|---|---|---|---|
| 1,515.20 | 1,22,393.86 | 24.53 | 18.12 | |
| 1,163.60 | 97,105.57 | 18.08 | 18.21 | |
| 1,751.50 | 4,20,135.55 | 36.75 | 17.76 | |
| 3,254.80 | 1,10,158.91 | 59.16 | 25.93 |
Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products primarily in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of... anti-infective, cardiovascular, gastrointestinal, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, and respiratory diseases. It provides consumer healthcare products, such as condoms, pregnancy detection kits, emergency contraceptives, antacid powders, vitamin and mineral supplements, and anti-acne preparations. The company offers its products primarily under the Manforce, Prega News, Unwanted-72, Gas-O-Fas, Health OK, and AcneStar brand names. In addition, it engages in the trading and exporting of pharmaceutical and health care products; manufacturing of packing materials ayurvedic products, packing materials, bulk drugs, and consumer goods; real estate, leasing, and hospitality businesses; and provision of IT services. The company was incorporated in 1991 and is based in New Delhi, India. Read more
Incorporated
1991
Chairman
Ramesh Juneja
Managing Director
Rajeev Juneja
Headquarters
New Delhi, Delhi
Website
Looking for more details about Mankind Pharma Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Mankind Pharma Ltd stood at ₹ 13,982 Cr as on 31-Dec-24
The share price of Mankind Pharma Ltd is ₹2,581.60 (NSE) and ₹2,582.65 (BSE) as of 17-Apr-2025 IST. Mankind Pharma Ltd has given a return of 13.18% in the last 1 years.
Mankind Pharma Ltd has a market capitalisation of ₹ 1,06,555 Cr as on 17-Apr-2025. As per Value Research classification, it is a Large Cap company.
The P/B ratio of Mankind Pharma Ltd is 7.64 times as on 17-Apr-2025, a 50% premium to its peers’ median range of 5.09 times.
The P/E ratio of Mankind Pharma Ltd is 52.20 times as on 17-Apr-2025, a 39% premium to its peers’ median range of 37.50 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Mankind Pharma Ltd and enter the required number of quantities and click on buy to purchase the shares of Mankind Pharma Ltd.
Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products primarily in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, and respiratory diseases. It provides consumer healthcare products, such as condoms, pregnancy detection kits, emergency contraceptives, antacid powders, vitamin and mineral supplements, and anti-acne preparations. The company offers its products primarily under the Manforce, Prega News, Unwanted-72, Gas-O-Fas, Health OK, and AcneStar brand names. In addition, it engages in the trading and exporting of pharmaceutical and health care products; manufacturing of packing materials ayurvedic products, packing materials, bulk drugs, and consumer goods; real estate, leasing, and hospitality businesses; and provision of IT services. The company was incorporated in 1991 and is based in New Delhi, India.
The prominent promoters of Mankind Pharma Ltd. are
| Name of promoters | Holding percentage |
|---|---|
|
Ramesh Juneja Family Trust (Held in the name of Ramesh Juneja, Managing Trustee) |
20.2%
|
|
Rajeev Juneja Family Trust (Held in the name of Rajeev Juneja, Managing Trustee) |
19.37%
|
|
Prem Sheetal Family Trust (Held in the name of Arora Family Private Limited, Trustee) |
14.97%
|
|
Sheetal Arora |
4.67%
|
|
Puja Juneja |
2.8%
|
The chairman of the company is Ramesh Juneja, and the managing director is Rajeev Juneja.
There is no promoter pledging in Mankind Pharma Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
4,20,136
|
|
|
1,22,394
|
|
|
1,10,159
|
|
|
97,106
|
| Mankind Pharma Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
20.49
|
|
Operating margin(%)
|
20.98
|
|
Net Margin(%)
|
17.06
|
|
Dividend yield(%)
|
0
|
Yes, TTM profit after tax of Mankind Pharma Ltd was ₹2,041 Cr.
₹61.60
(
